A Low Tacrolimus Concentration/Dose Ratio Increases the Risk for the Development of Acute Calcineurin Inhibitor-Induced Nephrotoxicity
Fast tacrolimus metabolism is linked to inferior outcomes such as rejection and lower renal function after kidney transplantation. Renal calcineurin-inhibitor toxicity is a common adverse effect of tacrolimus therapy. The present contribution hypothesized that tacrolimus-induced nephrotoxicity is re...
Authors: | |
---|---|
Division/Institute: | FB 05: Medizinische Fakultät |
Document types: | Article |
Media types: | Text |
Publication date: | 2019 |
Date of publication on miami: | 28.01.2021 |
Modification date: | 28.01.2021 |
Edition statement: | [Electronic ed.] |
Source: | Journal of Clinical Medicine 8 (2019) 10, 1586, 1-14 |
Subjects: | calcineurin inhibitor nephrotoxcity; tacrolimus; C/D ratio; tacrolimus metabolism; kidney transplantation |
DDC Subject: | 610: Medizin und Gesundheit |
License: | CC BY 4.0 |
Language: | Englisch |
Funding: | Finanziert durch den Open-Access-Publikationsfonds der Westfälischen Wilhelms-Universität Münster (WWU Münster) |
Format: | PDF document |
URN: | urn:nbn:de:hbz:6-48079527367 |
Other Identifiers: | DOI: 10.3390/jcm8101586 |
Permalink: | https://nbn-resolving.de/urn:nbn:de:hbz:6-48079527367 |
Related records: |
|
Digital documents: | 10.3390_jcm8101586.pdf
10.3390_jcm8101586_zusatzmaterial.pdf |
Download data: | ZIP File |
Fast tacrolimus metabolism is linked to inferior outcomes such as rejection and lower renal function after kidney transplantation. Renal calcineurin-inhibitor toxicity is a common adverse effect of tacrolimus therapy. The present contribution hypothesized that tacrolimus-induced nephrotoxicity is related to a low concentration/dose (C/D) ratio. We analyzed renal tubular epithelial cell cultures and 55 consecutive kidney transplant biopsy samples with tacrolimus-induced toxicity, the C/D ratio, C0, C2, and C4 Tac levels, pulse wave velocity analyses, and sublingual endothelial glycocalyx dimensions in the selected kidney transplant patients. A low C/D ratio (C/D ratio < 1.05 ng/mL×1/mg) was linked with higher C2 tacrolimus blood concentrations (19.2 ± 8.7 µg/L vs. 12.2 ± 5.2 µg/L respectively; p = 0.001) and higher degrees of nephrotoxicity despite comparable trough levels (6.3 ± 2.4 µg/L vs. 6.6 ± 2.2 µg/L respectively; p = 0.669). However, the tacrolimus metabolism rate did not affect the pulse wave velocity or glycocalyx in patients. In renal tubular epithelial cells exposed to tacrolimus according to a fast metabolism pharmacokinetic profile it led to reduced viability and increased Fn14 expression. We conclude from our data that the C/D ratio may be an appropriate tool for identifying patients at risk of developing calcineurin-inhibitor toxicity.